[go: up one dir, main page]

(Q27824835)

English

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group (English)
0 references
0 references
Michel Marty
0 references
Francesco Cognetti
0 references
Dominique Maraninchi
0 references
Ray Snyder
0 references
Louis Mauriac
0 references
Michèle Tubiana-Hulin
0 references
Stephen Chan
0 references
Antonio Antón
0 references
Ana Lluch
0 references
John Kennedy
0 references
Kenneth O'Byrne
0 references
Michael Green
0 references
Carol Ward
0 references
Karen Mayne
0 references
Jean-Marc Extra
0 references
1 July 2005
0 references
23
0 references
19
0 references
4265-74
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit